ProKidney Corp.

NASDAQ: PROK · Real-Time Price · USD
2.48
0.06 (2.48%)
At close: Aug 15, 2025, 12:19 PM

ProKidney Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
76K n/a n/a n/a
Cost of Revenue
n/a 3.17M 3.04M 1.98M
Gross Profit
76K -3.17M -3.04M -1.98M
Operating Income
-183.68M -151.52M -153.01M -55.11M
Interest Income
19.75M 22.08M 5.98M 2K
Pretax Income
-163.93M -129.45M -147.24M -55.11M
Net Income
-61.19M -35.47M -108.03M -55.15M
Selling & General & Admin
56.08M 44.81M 70.94M 8.86M
Research & Development
127.67M 106.71M 82.07M 46.26M
Other Expenses
n/a -3.17M n/a n/a
Operating Expenses
183.75M 148.35M 153.01M 55.11M
Interest Expense
9K 12K 215K n/a
Selling & Marketing Expenses
n/a 1.06M n/a n/a
Cost & Expenses
183.75M 151.52M 153.01M 55.11M
Income Tax Expense
-598K 6M 896K 38K
Shares Outstanding (Basic)
97.92M 61.71M 61.54M 31.89M
Shares Outstanding (Diluted)
97.92M 61.71M 61.54M 31.89M
EPS (Basic)
-0.62 -0.57 -1.76 -1.73
EPS (Diluted)
-0.62 -0.57 -1.76 -1.73
EBITDA
-158.49M -147.67M -143.99M -53.13M
EBIT
-163.92M -151.52M -147.02M -55.11M
Depreciation & Amortization
5.43M 3.85M 3.04M 1.98M